Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2009
11/10/2009US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/10/2009CA2590735C Process for the preparation of 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl) ethoxy}-5-tetrahydropyran-4-yloxyquinazoline, their intermediates and crystalline salts thereof
11/10/2009CA2491632C Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases
11/10/2009CA2417401C Benzofuran derivatives and their use as antibacterial agents
11/10/2009CA2416785C Novel arylethene-sulfonamides
11/10/2009CA2397593C Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
11/10/2009CA2353460C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
11/05/2009WO2009133861A1 Cyclic amine compound
11/05/2009WO2009133831A1 Phenylpropionic acid derivative and use thereof
11/05/2009WO2009133701A1 Phenylimidazole derivative and therepeutic and/or prophylactic agent for retinal/choroidal disorder
11/05/2009WO2009133692A1 Quinoline compound
11/05/2009WO2009133687A1 Cyclopentylacrylic acid amide derivative
11/05/2009WO2009133387A1 Indole- 3 -glyoxylamide derivatives for use as calcium ion channel modulators
11/05/2009WO2009133070A1 Imidazo-pyridine derivatives as activin-like receptor kinase (alk4 or alk5) inhibitors
11/05/2009WO2009132739A1 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
11/05/2009WO2009132453A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009WO2008075040A3 Radioactive pet agents for imaging ccr5 in vivo
11/05/2009US20090275756 2-oxetanone derivative and process for production thereof
11/05/2009US20090275753 Ortho-substituted aniline derivative and antioxidant drug
11/05/2009US20090275751 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
11/05/2009US20090275610 Tricyclic opioid modulators
11/05/2009US20090275572 Fab i inhibitors
11/05/2009US20090275565 Substituted aralkyl derivatives
11/05/2009CA2722813A1 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
11/05/2009CA2722733A1 Cyclopentylacrylamide derivative
11/05/2009CA2722704A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009CA2722131A1 Imidazo-pyridine derivatives as activin-like receptor kinase (alk4 or alk5) inhibitors
11/04/2009EP2113502A1 Hydrazyde type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
11/04/2009EP1723140B1 Process for the preparation of tryptase inhibitors
11/04/2009EP1720868B1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
11/04/2009EP1553092B1 Aralkyl formyl-alkyl piperazine derivatives and their uses as cerebral nerve protective agent
11/04/2009EP1499311B1 Substituted benzazoles and use thereof as raf kinase inhibitors
11/04/2009EP1446387B1 Substituted aryl 1,4-pyrazine derivatives
11/04/2009EP1425011B1 Enhancement of learning and memory and treatment of amnesia
11/04/2009EP1339684B1 Mch antagonists and their use in the treatment of obesity
11/04/2009EP1303488B1 Piperidine compounds for use as ccr-3 inhibitors
11/04/2009CN101573354A Substituted isoquinolines and their use as Rho-kinase inhibitors
11/04/2009CN101573343A HIV inhibiting 6-substituted pyrimidines
11/04/2009CN101573342A HIV inhibiting 5,6-substituted pyrimidines
11/03/2009US7612201 Pyrazole compounds
11/03/2009US7612094 Tri-substituted heteroaryls and methods of making and using the same
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612091 Caspase inhibitors and uses thereof
11/03/2009US7612090 Use in treatment of a disorder which is created by or is dependent upon decreased availability of serotonin, norepinephrine or dopamine
11/03/2009US7612075 Anticaogulants; cardiovascular disorders
11/03/2009US7612070 Indole derivative having heterocycle and mono- or diazaindole derivative
11/03/2009US7612064 Sulfopyrroles
11/03/2009US7612054 Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
11/03/2009CA2515507C Imaging system
11/03/2009CA2497074C Substituted spirocyclic ketoenols
11/03/2009CA2474510C Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/03/2009CA2372668C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
11/03/2009CA2341291C Pyridine ketones useful as herbicides
11/03/2009CA2318946C Process for the preparation of (-)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)piperidine
10/2009
10/29/2009WO2009132000A1 Quinoline or isoquinoline substituted p2x7 antagonists
10/29/2009WO2009131246A1 Sordarin derivatives for preventing or treating infectious diseases caused by pathogenic microorganisms
10/29/2009WO2009131173A1 2-aminoquinazoline derivative
10/29/2009WO2009131129A1 5-hydroxypyrimidine-4-carboxamide compound
10/29/2009WO2009131127A1 5-hydroxypyrimidine-4-carboxamide compound
10/29/2009WO2009130496A1 Substituted pyrimidin-5-carboxamides 281
10/29/2009WO2009130193A1 Fungicide hydroximoyl-heterocycles derivatives
10/29/2009WO2009109493A3 2-aminoquinoline derivatives as 5-ht ( 5a) receptor antagonists
10/29/2009WO2009106980A3 Indazole derivatives
10/29/2009US20090270475 Inhibition of bacterial biofilms with imidazole-phenyl derivatives
10/29/2009US20090270468 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
10/29/2009US20090270433 2,3-dihydro-iminoisoindole derivatives
10/29/2009US20090270417 Organic Compounds
10/29/2009US20090270374 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
10/29/2009US20090270372 Melanocortin receptor MC4 modulators; obesity, sexual disorders, anxiolytic agents, analgesics, antidepressants; 6-(aminomethyl)-2-aminobenzimidazole derivatives
10/29/2009US20090270367 Substituted hydroxyethylamine aspartyl protease inhibitors
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090270360 Dicarboxamide derivatives
10/29/2009US20090270256 Azolylmethyloxiranes, Use Thereof for Controlling Plant Pathogenic Fungi, and Agents Containing the Same
10/29/2009CA2722159A1 Substituted phenylimidazole compounds and their use as ido inhibitors
10/29/2009CA2722035A1 Quinoline or isoquinoline substituted p2x7 antagonists
10/29/2009CA2722028A1 5-hydroxypyrimidine-4-carboxamide compound
10/29/2009CA2719936A1 Substituted pyrimidin-5-carboxamides 281
10/28/2009EP2112140A1 Chinazolin derivatives, medicine containing these compounds, application thereof and method for their production
10/28/2009EP1973881B1 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides
10/28/2009EP1611126B1 Chromenone indoles
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009EP1272168B2 Small organic molecule regulators of cell proliferation
10/28/2009CN101568259A Azolylmethyloxiranes, their use for controlling phytopathogenic fungi, and compositions comprising them
10/28/2009CN101567425A Organic electroluminescence device, novel platinum complex compound and novel compound capable of being a ligand thereof
10/28/2009CN101565418A Amide derivative and purpose thereof
10/28/2009CN101565413A Isoflavone derivative modified by acetylaminoacid benzyl ester, preparation method and application thereof
10/28/2009CN101565412A Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
10/27/2009US7608634 Substituted pyrrolines as kinase inhibitors
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608621 Such as n-{[2-[(4-bromo-2-fluorophenyl)methyl]-5-hydroxy-6-(1-methylethyl)-3-oxo-2,3-dihydro-4-pyridazinyl]carbonyl}glycine; anemia; increasing erythropoietin production
10/27/2009US7608618 1-(2,2,2-trifluoroethanoyl)pyrrolidine-2-carboxylic acid [4-methoxy-3-(3-pyrazin-2-yl-ureido)phenyl]-amide; 4-Methoxy-N-(3-methylamino-propyl)-3-(3-pyrazin-2-yl-ureido)-benzamide; checkpoint kinase Chk1 inhibitor; chemosensitizing agents useful in the treatment of diseases related to DNA damage
10/27/2009US7608597 For therapy and prophylaxis of a Hepatitis C virus infection in a host
10/27/2009US7608590 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
10/27/2009US7608563 3-phenoxy-4-pyridazinol derivatives and herbicide composition containing the same
10/27/2009US7608244 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo; low molecular weight compounds; non-immunogenic
10/27/2009CA2564020C 6-o-substituted ketolides having antibacterial activity
10/27/2009CA2506441C 5-substituted-pyrazine or pyridine glucokinase activators
10/27/2009CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/27/2009CA2379021C New phenylpiperazines
10/27/2009CA2376355C N-heterocyclic derivatives as nos inhibitors
1 ... 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... 694